Global pharmaceutical companies have urged the Irish government to oppose new EU laws that will slash the amount of time between the launch of a new drug and rival firms being able to develop competing products.
The global chief executives of 27 companies wrote to Taoiseach Leo Varadkar in March raising concern over the proposals, which are the first major overhaul of the EU’s medicines regulations in 20 years and aim to make access to ...
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오: